Benzinga's Top #PreMarket Gainers

shares climbed 18.93 percent to $4.02 in pre-market trading after the company announced positive results from the Phase 1 study of OCR-002.

shares surged 10.85 percent to $38.30 in pre-market trading. Cellectis reported Q3 net loss of €0.36 per share, and total revenue and other income of €10.0 million.

gained 9.74 percent to $18.71 in pre-market trading after the company reported stronger-than-expected earnings for its fiscal fourth quarter.

shares rose 2.90 percent to $124.34 in pre-market trading after the company reported better-than-expected earnings for the third quarter.

shares rose 2.28 percent to $59.19 in pre-market trading after the company reported better-than-expected earnings for the third quarter on Tuesday.